Neurogene Inc. (NGNE) Capital expenditures 2016–2025
Neurogene Inc. (NGNE) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$1.2MFY2025 · since FY2016: $713,000 → $1.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.2M | +46.4% |
| FY2024 | $808,000 | +151.7% |
| FY2023 | $321,000 | -85.6% |
| FY2022 | $2.2M | -31.7% |
| FY2021 | $3.3M | +47.0% |
| FY2020 | $2.2M | +152.4% |
| FY2019 | $879,000 | +1693.9% |
| FY2018 | $49,000 | -90.1% |
| FY2017 | $494,000 | -30.7% |
| FY2016 | $713,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice